Evidence map›Paper›PMID 33622309›Full record

ArticleMalaria journal2021

Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Assosa zone, Ethiopia: implication for malaria diagnosis.

Gezahegn Solomon Alemayehu, Kayla Blackburn, Karen Lopez, Cheikh Cambel Dieng, Eugenia Lo, Daniel Janies, Lemu Golassa

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Local variability inMalariaWorld journal · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. High Prevalence ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Gezahegn Solomon AlemayehuAddis Ababa University, Aklilu Lemma Institute of Pathobiology, Addis Ababa, Ethiopia. gezasolo2020@gmail.com.
Kayla BlackburnDepartment of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Karen LopezDepartment of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Cheikh Cambel DiengDepartment of Biological Sciences, Charlotte, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Eugenia LoDepartment of Biological Sciences, Charlotte, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Daniel JaniesDepartment of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.
Lemu GolassaAddis Ababa University, Aklilu Lemma Institute of Pathobiology, Addis Ababa, Ethiopia.
University of North Carolina at Charlotte · USAddis Ababa University · ET

Funding

Comparative Genomics of Plasmodium vivax: Insights into Duffy Negative Erythrocyte InvasionR15AI138002 · NIAID · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI LO, EUGENIA · 2018 to 2018
$433k
Aklilu Lemma Institute of Pathobiology, Addis Ababa University Thematic research RD/LT/505/2016National Institute of Health NIH R15 AI138002NIAID NIH HHS R15 AI138002University of North Carolina at charlotte (Department of Bioinformatics and Genomics, College of Computing and Informatics, the Bioinformatics Research Center, the Department of Biological Sciences) and the Belk Family JANIES ENDOWMENT __62514
6 · The paper itself

Abstract

backgroundRapid diagnostic tests (RDTs) targeting histidine rich protein 2(HRP2) are widely used for diagnosis of Plasmodium falciparum infections. Besides PfHRP2, the PfHRP3 antigen contributes to the detection of P. falciparum infections in PfHRP2 RDTs. However, the performance HRP2-based RDT is affected by pfhrp2/3 gene deletions resulting in false-negative test results. The objective of this study was to determine the presence and prevalence of pfhrp2/3 gene deletions including the respective flanking regions among symptomatic patients in Assosa zone, Northwest Ethiopia.

methodsA health-facility based cross-sectional study was conducted in febrile patients seeking a malaria diagnosis in 2018. Blood samples were collected by finger-prick for microscopic examination of blood smears, malaria RDT, and molecular analysis using dried blood spots (DBS) prepared on Whatman filter paper. A total of 218 P. falciparum positive samples confirmed by quantitative PCR were included for molecular assay of pfhrp2/3 target gene.

resultsOf 218 P. falciparum positive samples, exon 2 deletions were observed in 17.9% of pfhrp2 gene and in 9.2% of pfhrp3 gene. A high proportion of deletions in short segments of pfhrp2 exon1-2 (50%) was also detected while the deletions of the pfhrp3 exon1-2 gene were 4.1%. The deletions were extended to the downstream and upstream of the flanking regions in pfhrp2/3 gene (above 30%). Of eighty-six PfHRP2 RDT negative samples, thirty-six lacked pfhrp2 exon 2. Five PfHRP2 RDT negative samples had double deletions in pfhrp2 exon 2 and pfhrp3 exon2. Of these double deletions, only two of the samples with a parasite density above 2000 parasite/µl were positive by the microscopy. Three samples with intact pfhrp3 exon2 in the pfhrp2 exon2 deleted parasite isolates were found to be positive by PfHRP2 RDT and microscopy with a parasite density above 10,000/µl.

conclusionThis study confirms the presence of deletions of pfhrp2/3 gene including the flanking regions. Pfhrp2/3 gene deletions results in false-negative results undoubtedly affect the current malaria control and elimination effort in the country. However, further countrywide investigations are required to determine the magnitude of pfhrp2/3 gene deletions and its consequences on routine malaria diagnosis.

Indexed as

Gene DeletionAdolescentAdultAgedAged, 80 and overAntigens, ProtozoanChildCross-Sectional StudiesDiagnostic Tests, RoutineEthiopiaFemaleHumansMalaria, FalciparumMaleMiddle AgedPlasmodium falciparumAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumHRP3 protein, Plasmodium falciparumProtozoan ProteinsAssosaEthiopiaMicroscopyPCRPfhrp2/3 gene deletionPfHRP2 RDTPlasmodium falciparum

Identifiers

PMID33622309
PMCPMC8095343
OpenAlexW3132420851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.